Dr. Eileen M. Deignan, MD

Dr. Deignan practices at Dermatology Associates of Concord Inc in Concord, Massachusetts.

Dr. Deignan's NPI, 1497723852, was assigned on March 10, 2006. Dr. Deignan graduated from Yale School of Medicine in 1995. Dr. Deignan's Massachusetts license number on file is 159436.

Dr. Deignan's primary practice is Dermatology Associates of Concord Inc, at 290 Baker Ave, Concord, MA 01742 in Middlesex County. The practice phone is (978) 369-9023.

Dr. Deignan's primary practice is Dermatology Associates of Concord Inc in Concord, Massachusetts. Dr. Deignan is also affiliated with Mount Auburn Hospital. The medical group on file is Dermatology Associates of Concord. Dmand AI also links Dr. Deignan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deignan practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Deignan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Deignan is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Deignan's licenses on file in 2 states: Massachusetts and Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and minor injury to a limb among the conditions Dr. Deignan treats.

CMS data shows 2,587 Medicare services from Dr. Deignan across 12 procedure codes in 2024, for 867 Medicare patients. Medicare paid $143,796 for them. Every service was in an office.

CMS counts 867 Medicare patients who saw Dr. Deignan in 2024. The largest group is 65 to 74, with 363 patients. 64% of them have high cholesterol, and 56% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Deignan's median patient age at 71, with 68% women.

In 2024, Dr. Deignan wrote 904 Medicare Part D claims for 398 patients. 93% of them were for generic drugs. CMS names the drug for 791 of them, across 19 drugs with 11 or more claims each, at $23,828 in total drug cost. In 2023, CMS named 796 claims across 17 drugs.

Dr. Deignan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deignan as offering telehealth. CMS counts 902 procedures of removal of skin lesions by Dr. Deignan, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Deignan. The most frequent topics are Amino Acid Sequence, Cell Compartmentation and Furin. Dr. Deignan's most frequent co-author is Jesse Davidson, MD, MPH.

CMS Open Payments shows 95 general payments to Dr. Deignan from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $753.

Dmand AI lists 1 award for Dr. Deignan.

Dr. Deignan graduated from Yale School of Medicine in 1995. Dr. Deignan is a member of AAD.

Dr. Deignan is in network with 4 carriers, including Aetna, Humana and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.